These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 22951781)
21. Neuropsychological functioning in a national cohort of severe traumatic brain injury: demographic and acute injury-related predictors. Sigurdardottir S; Andelic N; Wehling E; Roe C; Anke A; Skandsen T; Holthe OO; Jerstad T; Aslaksen PM; Schanke AK J Head Trauma Rehabil; 2015; 30(2):E1-12. PubMed ID: 24695265 [TBL] [Abstract][Full Text] [Related]
22. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial. Heiss WD; Brainin M; Bornstein NM; Tuomilehto J; Hong Z; Stroke; 2012 Mar; 43(3):630-6. PubMed ID: 22282884 [TBL] [Abstract][Full Text] [Related]
23. Magnesium sulfate for neuroprotection after traumatic brain injury: a randomised controlled trial. Temkin NR; Anderson GD; Winn HR; Ellenbogen RG; Britz GW; Schuster J; Lucas T; Newell DW; Mansfield PN; Machamer JE; Barber J; Dikmen SS Lancet Neurol; 2007 Jan; 6(1):29-38. PubMed ID: 17166799 [TBL] [Abstract][Full Text] [Related]
24. Neuroprotective treatment with cerebrolysin in patients with acute stroke: a randomised controlled trial. Ladurner G; Kalvach P; Moessler H; J Neural Transm (Vienna); 2005 Mar; 112(3):415-28. PubMed ID: 15583955 [TBL] [Abstract][Full Text] [Related]
25. Functional outcome 10 years after traumatic brain injury: its relationship with demographic, injury severity, and cognitive and emotional status. Ponsford J; Draper K; Schönberger M J Int Neuropsychol Soc; 2008 Mar; 14(2):233-42. PubMed ID: 18282321 [TBL] [Abstract][Full Text] [Related]
26. A prospective, randomized, placebo-controlled, double-blind trial about safety and efficacy of combined treatment with alteplase (rt-PA) and Cerebrolysin in acute ischaemic hemispheric stroke. Lang W; Stadler CH; Poljakovic Z; Fleet D; Int J Stroke; 2013 Feb; 8(2):95-104. PubMed ID: 23009193 [TBL] [Abstract][Full Text] [Related]
27. [The effect of cerebrolysin on moderate cognitive impairment in cerebral vascular insufficiency (a clinical and electrophysiological study)]. Damulin IV; Koberskaia NN; Mkhitarian EA Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(5):32-8. PubMed ID: 18379494 [TBL] [Abstract][Full Text] [Related]
28. Brain-derived neurotrophic factor in generalized anxiety disorder: results from a duloxetine clinical trial. Ball S; Marangell LB; Lipsius S; Russell JM Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():217-21. PubMed ID: 23313564 [TBL] [Abstract][Full Text] [Related]
30. The Effect of Cerebrolysin on Anxiety, Depression, and Cognition in Moderate and Severe Traumatic Brain Injury Patients: A CAPTAIN II Retrospective Trial Analysis. Mureșanu IA; Grad DA; Mureșanu DF; Hapca E; Benedek I; Jemna N; Strilciuc Ș; Popescu BO; Perju-Dumbravă L; Cherecheș RM Medicina (Kaunas); 2022 May; 58(5):. PubMed ID: 35630065 [No Abstract] [Full Text] [Related]
31. Aripiprazole improves various cognitive and behavioral impairments after traumatic brain injury: a case report. Umene-Nakano W; Yoshimura R; Okamoto T; Hori H; Nakamura J Gen Hosp Psychiatry; 2013; 35(1):103.e7-9. PubMed ID: 22703607 [TBL] [Abstract][Full Text] [Related]
32. [The prognostic significance of brain-derived neurotrophic factor (BDNF) for phobic anxiety disorders, vegetative and cognitive impairments during conservative treatment including adaptol of some functional and organic diseases of nervous system]. Zhivolupov SA; Samartsev IN; Marchenko AA; Puliatkina OV Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(4):37-41. PubMed ID: 22810739 [TBL] [Abstract][Full Text] [Related]
33. Positive effects of cerebrolysin on electroencephalogram slowing, cognition and clinical outcome in patients with postacute traumatic brain injury: an exploratory study. Alvarez XA; Sampedro C; Pérez P; Laredo M; Couceiro V; Hernández A; Figueroa J; Varela M; Arias D; Corzo L; Zas R; Lombardi V; Fernández-Novoa L; Pichel V; Cacabelos R; Windisch M; Aleixandre M; Moessler H Int Clin Psychopharmacol; 2003 Sep; 18(5):271-8. PubMed ID: 12920387 [TBL] [Abstract][Full Text] [Related]
35. [Cerebrolysin treatment of mild cognitive impairment of vascular genesis]. Damulin IV; Mkhitarian EA; Koberskaia NN Ter Arkh; 2007; 79(6):65-9. PubMed ID: 17684971 [TBL] [Abstract][Full Text] [Related]
36. Identifying longitudinal trajectories of emotional distress symptoms 5 years after traumatic brain injury. Sigurdardottir S; Andelic N; Roe C; Schanke AK Brain Inj; 2014; 28(12):1542-50. PubMed ID: 25029224 [TBL] [Abstract][Full Text] [Related]
37. Cerebrolysin in Alzheimer's disease: a randomized, double-blind, placebo-controlled trial with a neurotrophic agent. Panisset M; Gauthier S; Moessler H; Windisch M; J Neural Transm (Vienna); 2002 Jul; 109(7-8):1089-104. PubMed ID: 12111446 [TBL] [Abstract][Full Text] [Related]
38. The role of neuromediators and cytokines in the pathogenesis of acute traumatic brain injury. Selianina NV; Karakulova IuV; Eroshina OA Zh Vopr Neirokhir Im N N Burdenko; 2013; 77(6):22-6; discussion 27. PubMed ID: 24558751 [TBL] [Abstract][Full Text] [Related]
39. [An assessment of cerebrolysin effect on BDNF level in patients with post stroke aphasia depending on carbohydrate metabolism disorders]. Shishkova VN; Zotova LI; Maljukova NG; Sutjusheva IR; Kan NV; Gasanova EM; Kerimova EI Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(5):57-63. PubMed ID: 26356162 [TBL] [Abstract][Full Text] [Related]
40. The Montreal Cognitive Assessment in persons with traumatic brain injury. de Guise E; Alturki AY; LeBlanc J; Champoux MC; Couturier C; Lamoureux J; Desjardins M; Marcoux J; Maleki M; Feyz M Appl Neuropsychol Adult; 2014; 21(2):128-35. PubMed ID: 24826506 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]